Search results for "Real"

showing 10 items of 4449 documents

Dermoscopy of cutaneous smooth muscle neoplasms: a morphological study of 136 cases

2019

BACKGROUND: A variety of cutaneous smooth muscle neoplasms may arise in the skin and are frequently unrecognized by clinicians. There is sparse data relating to the dermoscopy of piloleiomyomas (PL), and nothing has been published about the dermoscopy of angioleiomyomas (AL) and leiomyosarcomas (LS). OBJECTIVES: To evaluate the morphological findings of a large series of cutaneous PL, AL and LS under dermoscopic observation, comparing these findings among them. METHODS: Digital dermoscopic images of 136 histopathologically confirmed cases of cutaneous smooth muscle neoplasms (114 PL, 13 AL and 9 LS) collected from 10 Hospitals in Spain, Austria and Italy were evaluated for the presence of d…

AdultLeiomyosarcomaMaleLeiomyosarcomaPathologymedicine.medical_specialtySkin NeoplasmsAngiomyomaDermoscopyDermoscopy angioleiomyoma leiomyosarcoma piloleiomyoma smooth muscle tumorsDiagnostic accuracyDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineSmooth musclemedicineHumansAgedDermoscopy; angioleiomyoma; leiomyosarcoma ; piloleiomyoma; smooth muscle tumorssmooth muscle tumorsbusiness.industryLarge seriesMuscle SmoothleiomyosarcomaMiddle Agedangioleiomyomamedicine.diseaseAngiomyomaInfectious Diseases030220 oncology & carcinogenesisMuscleFemaleSmoothpiloleiomyomaAdult; Aged; Angiomyoma; Female; Humans; Leiomyosarcoma; Male; Middle Aged; Muscle Smooth; Skin Neoplasms; DermoscopybusinessJournal of the European Academy of Dermatology and Venereology
researchProduct

Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group

2020

Background: Worldwide multiple sclerosis (MS) centers have coordinated their efforts to use data acquired in clinical practice for real-world observational studies. In this retrospective study, we aim to harmonize outcome measures, and to evaluate their heterogeneity within the Rising Italian Researchers in MS (RIReMS) study group. Methods: RIReMS members filled in a structured questionnaire evaluating the use of different outcome measures in clinical practice. Thereafter, thirty-four already-published papers from RIReMS centers were used for heterogeneity analyses, using the DerSimonian and Laird random-effects method to compute the between-study variance (τ2). Results: Based on questionna…

AdultLongitudinal studymedicine.medical_specialtyHarmonizationOutcome measuresMultiple sclerosisOutcome measure03 medical and health sciences0302 clinical medicineHarmonization; Multiple sclerosis; Outcome measures; Real worldmedicineHumansMultiple sclerosi030212 general & internal medicineAge of OnsetAgedRetrospective StudiesExpanded Disability Status Scalebusiness.industryMultiple sclerosisOutcome measuresRetrospective cohort studyReal worldGeneral MedicineVariance (accounting)medicine.diseaseNeurologyItalyHarmonizationFamily medicineObservational studyFemaleNeurology (clinical)business030217 neurology & neurosurgeryHarmonization; Multiple sclerosis; Outcome measures; Real world; Adult; Age of Onset; Aged; Female; Humans; Italy; Retrospective Studies; Multiple Sclerosis
researchProduct

Are Asthmatics Enrolled in Randomized Trials Representative of Real-Life Outpatients?

2014

<b><i>Background/Objective:</i></b> This study was aimed at exploring to what extent populations enrolled in randomized controlled trials (RCTs) of inhalation combination treatment for mild/moderate asthma in adults are fully representative of ‘real-life' populations. The following is a retrospective analysis of the clinical records of outpatient subjects with an ascertained diagnosis of asthma. <b><i>Methods:</i></b> A retrospective analysis was performed. Stable conditions, such as smoking habit and chronic diseases other than asthma, were identified as exclusion criteria for RCTs. The selected criteria were then applied to asthmatic outpati…

AdultLung DiseasesMalePulmonary and Respiratory Medicinemedicine.medical_specialtyPediatricsAdolescentResearch SubjectsAlternative medicineMEDLINECoronary Artery DiseaseAnxietySettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.inventionYoung AdultRandomized controlled triallawmedicineHumansYoung adultAgedRandomized Controlled Trials as TopicRetrospective StudiesAsthmaAged 80 and overInhalationDepressionbusiness.industryPatient SelectionSmokingAge FactorsReal-lifeArrhythmias CardiacRetrospective cohort studyMiddle Agedmedicine.diseaseAsthmaRandomized controlled trialFemaleObservational studybusiness
researchProduct

Growth hormone replacement in adults:Real-world data from two large studies in US and Europe

2020

Objective: This report describes the effectiveness and safety of growth hormone replacement in 3180 adult patients with growth hormone deficiency followed-up for 0.0–12.2 years in two completed, complementary, non-interventional, multicentre studies, NordiNet® International Outcome Study (IOS) (NCT00960128) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program (NCT01009905). Design: In both studies, Norditropin® (somatropin; Novo Nordisk A/S, Denmark) was administered at the discretion of the treating physician and according to routine practice. We present data on baseline characteristics, growth hormone dose, safety data and change from baseline in waist circumferenc…

AdultMale0301 basic medicineIGF-I SDSPediatricsmedicine.medical_specialtyWaistHormone Replacement TherapyEndocrinology Diabetes and MetabolismANSWER Program030209 endocrinology & metabolismEffectivenessGrowth hormoneNordiNet® International Outcome Study (IOS)Body compositionHypopituitarismBody Mass IndexGrowth hormone deficiency03 medical and health sciences0302 clinical medicineEndocrinologyElectric ImpedancemedicineHumansGrowth hormone replacementAgedAdult patientsHuman Growth Hormonebusiness.industryMiddle Agedmedicine.diseaseRecombinant ProteinsUnited StatesReal-world dataEuropeClinical Practice030104 developmental biologyGrowth hormone deficiency in adultsBaseline characteristicsBody CompositionFemaleWaist CircumferenceSafetybusinessReal world dataBody mass index
researchProduct

Performance characteristics of the new Abbott Real Time MTB assay for detection of Mycobacterium tuberculosis complex in respiratory specimens

2015

The performance of the Abbott Real Time MTB assay for detection of Mycobacterium tuberculosis complex in respiratory specimens was evaluated using a standard culture as the reference. The overall concordance between both methods was 0.95. The assay displayed an excellent sensitivity (100% for smear-positive/92.3% for smear-negative specimens) and specificity (100%).

AdultMale0301 basic medicineMicrobiology (medical)AdolescentConcordance030106 microbiologyReal-Time Polymerase Chain ReactionSensitivity and SpecificityMycobacterium tuberculosisYoung Adult03 medical and health sciences0302 clinical medicineHumansMedicine030212 general & internal medicineRespiratory systemChildTuberculosis PulmonaryAgedAged 80 and overbiologybusiness.industryReproducibility of ResultsMycobacterium tuberculosisGeneral MedicineMiddle Agedbiology.organism_classificationVirologyInfectious DiseasesMycobacterium tuberculosis complexChild PreschoolFemaleReagent Kits DiagnosticbusinessDiagnostic Microbiology and Infectious Disease
researchProduct

Performance of a Highly Sensitive Mycobacterium tuberculosis Complex Real-Time PCR Assay for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence …

2018

ABSTRACT The potential impact of routine real-time PCR testing of respiratory specimens from patients with presumptive tuberculosis in terms of diagnostic accuracy and time to tuberculosis treatment inception in low-prevalence settings remains largely unexplored. We conducted a prospective intervention cohort study. Respiratory specimens from 1,020 patients were examined by acid-fast bacillus smear microscopy, tested by a real-time Mycobacterium tuberculosis complex PCR assay (Abbott RealTi me MTB PCR), and cultured in mycobacterial media. Seventeen patients tested positive by PCR (5 were acid-fast bacillus smear positive and 12 acid-fast bacillus smear negative), and Mycobacterium tubercul…

AdultMale0301 basic medicineMicrobiology (medical)medicine.medical_specialtyTime FactorsTuberculosisAdolescent030106 microbiologyAntitubercular AgentsReal-Time Polymerase Chain ReactionMycobacterium tuberculosisYoung Adult03 medical and health sciencesTuberculosis diagnosisInternal medicineHumansMedicineProspective StudiesTuberculosis PulmonaryAgedAged 80 and overBacteriological TechniquesMicroscopybiologybusiness.industryMycobacteriology and Aerobic ActinomycetesMycobacterium tuberculosisMiddle Agedmedicine.diseasebiology.organism_classificationIntervention studiesReal-time polymerase chain reactionMolecular Diagnostic TechniquesMycobacterium tuberculosis complexFemaleNontuberculous mycobacteriabusinessCohort studyJournal of Clinical Microbiology
researchProduct

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.

2020

Background: Current availability of several biologic treatments for severe asthma makes it possible to choose the most appropriate for each patient. Sometimes a good percentage of patients with severe asthma may be eligible for biologics that target either the allergic phenotype or the eosinophilic one, but not all respond to that selected as first choice. The aim of our real-life study was to assess whether, for patients with severe eosinophilic allergic asthma, not previously controlled by the anti-IgE omalizumab, the shift to another biologic targeting interleukin-5, such as mepolizumab, may represent a good therapeutic choice. Methods: A total of 41 consecutive patients with severe, per…

AdultMale0301 basic medicinePulmonary and Respiratory Medicinesevere asthmamedicine.medical_specialtyTime FactorsSevere asthmamepolizumab omalizumab severe asthma switchingOmalizumabSettore MED/10 - Malattie Dell'Apparato RespiratorioAntibodies Monoclonal HumanizedSeverity of Illness Index03 medical and health sciences0302 clinical medicinereal lifeAnti-Allergic AgentsHumansMedicineswitching.Pharmacology (medical)Anti-Asthmatic AgentsPulmonary EosinophiliaIntensive care medicineLungOriginal ResearchAgedRetrospective Studieslcsh:RC705-779switchingDrug Substitutionbusiness.industrymepolizumablcsh:Diseases of the respiratory systemMiddle AgedAsthmaTreatment Outcome030104 developmental biologyItaly030228 respiratory systemomalizumabFemalebusinessMepolizumabmedicine.drug
researchProduct

Lack of TERT promoter mutations in melanomas with extensive regression

2015

AdultMale0301 basic medicineTelomeraseSkin NeoplasmsDermatologyTert promoter030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineHumansPromoter Regions GeneticMelanomaTelomeraseAgedbusiness.industryMelanomaCase-control studyMiddle Agedmedicine.diseaseRegressionNeoplasm regression030104 developmental biologyNeoplasm Regression SpontaneousCase-Control StudiesMutationMutation (genetic algorithm)Cancer researchFemalebusinessJournal of the American Academy of Dermatology
researchProduct

Kinetics of torque teno virus DNA load in saliva and plasma following allogeneic hematopoietic stem cell transplantation

2018

Plasma torque teno virus (TTV) DNA load directly correlates with the degree of T-cell immune reconstitution early after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Here, the kinetics of oral TTV DNA shedding was examined to assess whether quantitation of TTV DNA load in saliva may either replace or complement that in plasma for predicting lymphocyte (ALC) reconstitution after engraftment. This prospective observational study enrolled 38 nonconsecutive allo-HSCT recipients. Saliva and plasma specimens were collected at baseline (pretransplant) and at around days +30, +50, and +90 after allo-HSCT. TTV DNA was quantitated in both specimen types by real-time PCR. ALCs were m…

AdultMale0301 basic medicineTorque teno virusSalivaOral TTV DNA sheddingLymphocytemedicine.medical_treatmentTTV DNAemiaAllogeneic hematopoietic stem cell transplantation (allo-HSCT)Hematopoietic stem cell transplantationReal-Time Polymerase Chain ReactionTorque teno virus (TTV)Plasma03 medical and health sciences0302 clinical medicineImmune systemVirologymedicineHumansTransplantation HomologousProspective StudiesAllogeneic hematopoietic stem cell transplantation (allo-HSCT); Immune reconstitution; Oral TTV DNA shedding; Saliva; Torque teno virus (TTV); TTV DNAemia; Virology; Infectious DiseasesSalivaAgedTorque teno virusbusiness.industryHematopoietic Stem Cell TransplantationMiddle AgedImmune reconstitutionVirologyDNA Virus InfectionsTransplantation030104 developmental biologyInfectious Diseasesmedicine.anatomical_structureReal-time polymerase chain reactionDNA ViralFemalebusinessCytometry030215 immunologyJournal of Medical Virology
researchProduct

Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals

2018

The emergence of resistance-associated substitutions (RASs) can compromise the high efficacy of direct-acting antivirals (DAAs). Little is known about RASs selection at very early time points during DAA treatment. Therefore, we analyzed the potential emergence of RASs immediately after therapy initiation. Samples of 71 patients treated with different DAAs were collected at baseline, during therapy (hours 4 and 8; days 1-7; weeks 2-4) or until target not detected. HCV-RNA levels were determined by qPCR, and RASs were detected by deep sequencing. Sixty-three (89%) patients achieved a sustained virological response (SVR), 7 (10%) relapsed, and 1 (1%) experienced a breakthrough. Almost all non-…

AdultMale0301 basic medicinemedicine.medical_specialtySustained Virologic ResponseHepatitis C virusHepacivirusViral quasispeciesReal-Time Polymerase Chain ReactionDIRECT ACTING ANTIVIRALSmedicine.disease_causeAntiviral AgentsGastroenterologyDeep sequencingVirological response03 medical and health sciences0302 clinical medicineRecurrenceGenetic EvolutionVirologyInternal medicineDrug Resistance ViralHumansMedicineProspective StudiesSelection GeneticAgedAged 80 and overHepatologybusiness.industryAntiviral therapyvirus diseasesHepatitis C ChronicMiddle AgedViral Loaddigestive system diseases030104 developmental biologyInfectious DiseasesAmino Acid SubstitutionRNA ViralFemale030211 gastroenterology & hepatologySensitivity limitbusinessJournal of Viral Hepatitis
researchProduct